Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.
Kumar M, Nagpal R, Kumar R, Hemalatha R, Verma V, Kumar A, Chakraborty C, Singh B, Marotta F, Jain S, Yadav H.
Kumar M, et al. Among authors: kumar r, kumar a.
Exp Diabetes Res. 2012;2012:902917. doi: 10.1155/2012/902917. Epub 2012 May 3.
Exp Diabetes Res. 2012.
PMID: 22611376
Free PMC article.
Review.